Sitagliptin 100mg + Metformin Hydrochloride PR 500mg Tablets

Sitagliptin 100mg + Metformin Hydrochloride PR 500mg combines sitagliptin with metformin for adults with type 2 diabetes as combination therapy. Sitagliptin improves glucose-dependent incretin signaling, while metformin lowers hepatic glucose production and improves insulin sensitivity. The combination targets fasting and post-meal glucose without simply repeating one mechanism. It is intended for type 2 diabetes, not type 1 diabetes or diabetic ketoacidosis.
Take Sitagliptin 100mg + Metformin Hydrochloride PR 500mg exactly as prescribed, usually with meals to improve metformin tolerability. Extended-release tablets should usually be swallowed whole. Kidney function should be checked as advised.
Sitagliptin inhibits DPP-4 to support incretin activity. Metformin lowers liver glucose output and improves insulin sensitivity.
Possible effects include nausea, diarrhea, abdominal discomfort, metallic taste, headache, and low blood sugar with insulin or sulfonylureas. Serious concerns include lactic acidosis, pancreatitis, allergic swelling, severe joint pain, kidney problems, bullous pemphigoid, and heart-failure symptoms.
Review eGFR, dehydration, severe infection, liver disease, heart failure, alcohol use, contrast imaging, surgery, pancreatitis history, pregnancy, breastfeeding, insulin, sulfonylureas, and extended-release swallowing instructions.
Type 2 diabetes mellitus in adults when sitagliptin plus metformin therapy is prescribed.
Combines incretin support with reduced liver glucose production to improve glucose control when both medicines suit the patient.
Sitagliptin 100mg + Metformin Hydrochloride PR 500mg is used for type 2 diabetes for sitagliptin plus metformin treatment.
Taking it with meals can reduce metformin-related stomach upset and may improve tolerance during diabetes treatment.
Kidney function affects sitagliptin dosing and metformin safety.
It is a rare but serious metformin-associated acid buildup risk, more likely with kidney failure, dehydration, severe illness, or heavy alcohol use.
Severe abdominal pain, repeated vomiting, slow breathing, unusual muscle pain, extreme weakness, swelling, or allergic symptoms need review.
Sitagliptin metformin, DPP-4 inhibitor metformin, Type 2 diabetes combination, Kidney function eGFR, Lactic acidosis warning, Pancreatitis warning, AR: Sitagliptin + Metformin Hydrochloride PR أقراص, FR: Sitagliptin + Metformin Hydrochloride PR comprimé, PT: Sitagliptin + Metformin Hydrochloride PR comprimido, ES: Sitagliptin + Metformin Hydrochloride PR tableta, RU: Sitagliptin + Metformin Hydrochloride PR таблетки, ID: Sitagliptin + Metformin Hydrochloride PR, VI: Sitagliptin + Metformin Hydrochloride PR viên nén, MS: Sitagliptin + Metformin Hydrochloride PR, TL: Sitagliptin + Metformin Hydrochloride PR tableta, ZH-SG: Sitagliptin + Metformin Hydrochloride PR 片剂
International B2B Enquiry
Send a structured B2B enquiry for Sitagliptin 100mg + Metformin Hydrochloride PR 500mg Tablets under Diabetes Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Sitagliptin 100mg + Metformin Hydrochloride PR 500mg Tablets